 Home > Biochemistry News > Biotechnology News > Positive Phase 2 Clinical Results of LAG-3 Therapy for Non-Small Cell Lung Cancer

Positive Phase 2 Clinical Results of LAG-3 Therapy for Non-Small Cell Lung Cancer

 Last Update: 2022-04-22
 Source: Internet
 Author: User

Tags

chemical safety signs

effervescent soluble medications

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Today, Immutep announced that its LAG-3 fusion protein eftilagimod alpha (efti, also known as IMP321), in combination with Merck & Co.

LAG-3 protein can regulate the signaling pathway of T lymphocytes and antigen presenting cells (APCs), and plays an important role in adaptive immune response

Image source: Immutep official website

Eftilagimod alpha is a soluble LAG-3 fusion protein

In this part of the clinical trial, 36 advanced patients were treated

The test results show:

73.

73% of patients were still alive 6 months after treatment

The disease control rate was 36.

The objective response rate was 5.

Median overall survival has not been reached

Image source: Reference [1]

Dr.

References:

[1] Immutep's efti in combination with MSD's pembrolizumab shows encouraging antitumor activity in difficult to treat 2nd line metastatic lung cancer patients.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.